瑞普生物

- 300119

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
瑞普生物(300119) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入158,716.4899,409.6344,278.05208,425.04147,676.10
营业收入158,716.4899,409.6344,278.05208,425.04147,676.10
二、营业总成本131,439.7582,388.9136,181.26173,193.14121,510.23
营业成本77,853.7947,738.1321,707.24107,461.3177,215.52
营业税金及附加1,514.421,023.98368.582,040.011,306.87
销售费用26,662.1217,638.607,018.8634,407.4224,551.17
管理费用11,556.887,360.383,367.2014,281.869,844.81
财务费用1,434.16929.23513.361,734.691,148.47
研发费用12,418.387,698.593,206.0213,267.857,443.39
资产减值损失----------
公允价值变动收益2,977.672,196.171,476.435,138.321,841.58
投资收益2,360.212,139.31-30.08405.09159.82
其中:对联营企业和合营企业的投资收益2,343.252,131.15-35.8882.84-125.00
汇兑收益----------
三、营业利润32,671.8421,589.039,853.4341,663.8428,466.67
加:营业外收入48.9411.5510.72342.37312.48
减:营业外支出112.2389.9445.81625.07285.77
其中:非流动资产处置损失----------
四、利润总额32,608.5521,510.639,818.3341,381.1428,493.39
减:所得税费用3,118.462,163.241,068.054,004.152,891.77
五、净利润29,490.1019,347.398,750.2837,376.9925,601.62
归属于母公司所有者的净利润27,369.8017,827.118,082.3534,669.8723,302.08
少数股东损益2,120.301,520.28667.942,707.122,299.54
六、每股收益
基本每股收益(元/股)0.59000.38430.17420.74880.5036
稀释每股收益(元/股)0.59000.38430.17420.74880.5036
七、其他综合收益----------
八、综合收益总额29,490.1019,347.398,750.2837,376.9925,601.62
归属于母公司所有者的综合收益总额27,369.8017,827.118,082.3534,669.8723,302.08
归属于少数股东的综合收益总额2,120.301,520.28667.942,707.122,299.54
下载全部历史数据到excel中 返回页顶